We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





US National COVID-19 Diagnostic Supply Registry Launched to Provide Updates on Molecular, Antigen and Serology Tests Shipments

By LabMedica International staff writers
Posted on 23 Jul 2020
Print article
Illustration
Illustration
A new US national testing registry has been launched to aid in the fight against COVID-19 and has released the first data set that shows more than 65 million tests have been shipped nationwide since the beginning of the pandemic.

This comprehensive, national COVID-19 diagnostic supply registry has been created by the Advanced Medical Technology Association (AdvaMed Washington, D.C., USA) to help state and federal governments in their pandemic responses. The national registry is being launched in partnership with 13 commercial diagnostics manufacturers: Abbott, BD, bioMérieux, Bio-Rad, Beckman Coulter, Cepheid, Hologic, Ortho Clinical Diagnostics, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. AdvaMed has been working closely with the White House, HHS, FDA, FEMA and other key government agencies to ensure the continued supply of diagnostics tests, as well as other vital medical equipment such as PPE and ventilators, in the fight against the COVID-19 pandemic.

AdvaMed’s registry will compile information from diagnostic companies along with publicly available data on daily tests performed to create a centralized and standardized COVID-19 diagnostic supply registry. It will provide weekly state- and national-level updates on the number of molecular, antigen, and serology (antibody) tests shipped in the US. AdvaMed’s registry will help streamline communications and data sharing between diagnostic companies and federal and state governments as well as standardize test supply reporting. It will also facilitate collaboration with laboratories and other public health stakeholders to optimize access to all platforms of COVID-19 testing so that any potential shortages are identified and addressed quickly. The registry’s first publicly released dataset shows that since the beginning of the pandemic, more than 65 million tests have been manufactured and shipped nationwide, with test shipments now topping 800,000 daily.

“It is absolutely vital to our nation’s health and economic recovery that we have sufficient supplies to test everyone who needs it, and, just as important, to know where these supplies are so we can get them where they are most needed,” said Scott Whitaker, president and CEO of AdvaMed. “This national registry will be a crucial tool for federal and state authorities as they work to protect both patients and health care providers and move to reopen the U.S. economy.”

“We hope this registry serves as a key tool in our fight against COVID-19. We stand ready to partner with all providers, laboratories and other key stakeholders in the testing ecosystem to collaborate with the federal and state governments to coordinate efforts to support patient care and public health. Further, we stand ready to work with our partners in the federal government on any policies that would allow this registry to better serve patients and providers in need,” Whitaker concluded.

Related Links:
Advanced Medical Technology Association (AdvaMed)

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.